ASYS vs ACMR vs ICHR vs AXTI vs COHU

For growth investors, ACM Research, Inc.

(ACMR) is the stronger pick with 15. 2% revenue growth year-over-year, versus -21. 6% for Amtech Systems, Inc. (ASYS). ACM Research, Inc. (ACMR) offers the better valuation at 43. 7x trailing P/E (30. 8x forward), making it the more compelling value choice. Analysts rate Amtech Systems, Inc. (ASYS) a "Buy" — based on 9 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On forward P/E, ACM Research, Inc.

is actually cheaper at 30. 8x.

Over the past 5 years, AXT, Inc.

(AXTI) delivered a total return of +1196%, compared to +35. 5% for Cohu, Inc. (COHU). Over 10 years, the gap is even starker: AXTI returned +36. 2% versus ASYS's +257. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Amtech Systems, Inc.

(ASYS) is the lower-risk stock at 1. 84β versus AXT, Inc. 's 4. 06β — meaning AXTI is approximately 121% more volatile than ASYS relative to the S&P 500. On balance sheet safety, ACM Research, Inc. (ACMR) carries a lower debt/equity ratio of 16% versus 46% for Cohu, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), ACM Research, Inc.

(ACMR) is pulling ahead at 15. 2% versus -21. 6% for Amtech Systems, Inc. (ASYS). On earnings-per-share growth, the picture is similar: Cohu, Inc. grew EPS -6. 7% year-over-year, compared to -253. 3% for Amtech Systems, Inc.. Over a 3-year CAGR, ACMR leads at 32. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

ACM Research, Inc.

(ACMR) is the more profitable company, earning 10. 4% net margin versus -38. 2% for Amtech Systems, Inc. — meaning it keeps 10. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ACMR leads at 12. 1% versus -35. 9% for ASYS. At the gross margin level — before operating expenses — ACMR leads at 44. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, ACM Research, Inc.

(ACMR) trades at 30. 8x forward P/E versus 468. 6x for AXT, Inc. — 437. 8x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ACMR: 25. 3% to $75. 00.

In this comparison, ACMR (0.

2% yield) pays a dividend. ASYS, ICHR, AXTI, COHU do not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Ichor Holdings, Ltd.

(ICHR) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (+661. 7% 10Y return). ACM Research, Inc. (ACMR) carries a higher beta of 3. 17 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (ICHR: +661. 7%, ACMR: +31. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Technology sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: ASYS is a small-cap quality compounder stock; ACMR is a small-cap high-growth stock; ICHR is a small-cap quality compounder stock; AXTI is a small-cap quality compounder stock; COHU is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.